FTSE 100 pharma giant GSK kicks off Zantac appeal as company seeks to limit damages

FTSE 100 pharma giant GSK kicks off Zantac appeal as company seeks to limit damages

City A.M.

Published

GSK has launched an appeal against the Delaware Superior Court's recent so-called Daubert ruling.

Full Article